Execute a corporate, proactive, worldwide anti-counterfeit strategy focused on securing the supply chain, detecting and responding to counterfeit events, and raising awareness of the risks of counterfeit pharmaceutical products
Take actions to raise public awareness of the risks posed by counterfeits and advocate for increasing enforcement and shaping relevant regulatory requirements
Train key stakeholders and business partners in the identification of suspicious activities and/or suspected counterfeit products
Continue to partner with industry groups to provide advocacy on high-priority anti-counterfeiting policy initiatives, and explore new partnership opportunities with patients and other external stakeholders
Develop metrics to gauge the impact of specific actions to ensure that resources remain focused on the areas that can have greatest benefit
Continue advocacy efforts to support the development of a standardized system to identify and code medical products
